2021-07-13T09:22:32Z
2021-07-13T09:22:32Z
2021-06-10
2021-07-13T09:22:32Z
Microbial infections are a major public health concern. Antimicrobial peptides (AMPs) have been demonstrated to be a plausible alternative to the current arsenal of drugs that has become inefficient due to multidrug resistance. Herein we describe a new AMP family, namely the supercationic peptide dendrimers (SCPDs). Although all members of the series exert some antibacterial activity, we propose that special attention should be given to (KLK)2KLLKLL-NH2 (G1KLK-L2KL2), which shows selectivity for Gram-negative bacteria and virtually no cytotoxicity in HepG2 and HEK293. These results reinforce the validity of the SCPD family as a valuable class of AMP and support G1KLK-L2KL2 as a strong lead candidate for the future development of an antibacterial agent against Gram-negative bacteria.
Article
Published version
English
Síntesi en fase sólida; Pèptids; Antibiòtics; Bacteris gramnegatius; Solid-phase synthesis; Peptides; Antibiotics; Gram-negative bacteria
MDPI
Reproducció del document publicat a: https://doi.org/10.3390/antibiotics10060695
Antibiotics, 2021, vol. 10, num. 6, p. 695
https://doi.org/10.3390/antibiotics10060695
cc-by (c) Ramchuran, Estelle J. et al., 2021
https://creativecommons.org/licenses/by/4.0/